Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine transdermal patch for perioperative analgesia in foot and ankle surgery
ChiCTR-IPR-17012931Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of buprenorphine in postoperative pain (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: Visual Analog Scale pain score at 3 months and AOFAS score at 3 months. Planned start Nov 2017; status: not yet recruiting.
02
Drugs
buprenorphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR-IPR-17012931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012931.